(Q45292529)

11 December 2017

Plasma catecholamine levels after fluoxetine treatment in depressive patients (English)

1 reference

11 December 2017

1 reference

Patrizia Blardi

1

1 reference

11 December 2017

Arianna de Lalla

2

1 reference

11 December 2017

Alberto Auteri

3

1 reference

11 December 2017

Sonia Iapichino

4

1 reference

11 December 2017

Alice Dell'Erba

5

1 reference

11 December 2017

Paolo Castrogiovanni

6

1 reference

11 December 2017

1 January 2005

1 reference

11 December 2017

1 reference

11 December 2017

51

1 reference

11 December 2017

2

1 reference

11 December 2017

72-76

1 reference

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

11 December 2017

1 reference

Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories

21 January 2018

1 reference

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

21 January 2018

1 reference

In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine

21 January 2018

1 reference

Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex.

21 January 2018

1 reference

Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats

21 January 2018

1 reference

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

21 January 2018

1 reference

Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder

21 January 2018

1 reference

Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression

21 January 2018

1 reference

Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment

21 January 2018

1 reference

Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients

21 January 2018

1 reference

Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat.

21 January 2018

1 reference

Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.

21 January 2018

1 reference

8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors.

21 January 2018

1 reference

Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (+/-)-MDL 73005EF and its enantiomers.

21 January 2018

1 reference

Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers

21 January 2018

1 reference

R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000084163

1 reference

11 December 2017

1 reference